Neuroprotective effects of huperzine A: New therapeutic targets for neurodegenerative disease

Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,290 · see citing works

Hydrogen peroxide mediates amyloid β protein toxicity

Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · see citing works

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Perry, E., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P., & Perry, R. H. (1978) · British medical journal · doi:10.1136/bmj.2.6150.1457 · Cited by 2,043 · see citing works

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417 · see citing works

Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor

Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403 · see citing works

Amyloid, the presenilins and Alzheimer’s disease

Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370 · see citing works

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086 · see citing works

The mitochondrion in apoptosis: how Pandora's box opens

Zamzami, N., & Kroemer, G. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048073 · Cited by 1,029 · see citing works

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.

Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., & Cotman, C. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7951 · Cited by 1,022 · see citing works

Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine Receptors

Nitsch, R. M., Slack, B. E., Wurtman, R. J., & Growdon, J. H. (1992) · Science · doi:10.1126/science.1411529 · Cited by 898 · see citing works

Alzheimer's Disease--Genotypes, Phenotype, and Treatments

Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 871 · see citing works

Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide

Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 833 · see citing works

Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein

Mattson, M. P., Cheng, B., Culwell, A. R., Esch, F. S., Lieberburg, I. M., & Rydel, R. E. (1993) · Neuron · doi:10.1016/0896-6273(93)90315-i · Cited by 795 · see citing works

Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777 · see citing works

α ₂ -Adrenergic Mechanisms in Prefrontal Cortex Associated with Cognitive Decline in Aged Nonhuman Primates

Arnsten, A. F. T., & Goldman-Rakic, P. S. (1985) · Science · doi:10.1126/science.2999977 · Cited by 549 · see citing works

The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory

Decker, M. W., & McGaugh, J. L. (1991) · Synapse · doi:10.1002/syn.890070209 · Cited by 524 · see citing works

Apoptosis driven by IP3‐linked mitochondrial calcium signals

Szalai, G., Krishnamurthy, R., & Hajnóczky, G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6349 · Cited by 495 · see citing works

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine1

WANG, R., YAN, H., & TANG, X.-C. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00255.x · Cited by 470 · see citing works

Diffuse transmission by acetylcholine in the CNS

Descarries, L., Gisiger, V., & Steriade, M. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00050-6 · Cited by 406 · see citing works

A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth

Small, D. H., Nurcombe, V., Reed, G., Clarris, H. J., Moir, R. D., Beyreuther, K. T., & Masters, C. L. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02117.1994 · Cited by 389 · see citing works

Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders

Youdim, M. B. H., & Buccafusco, J. J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.11.007 · Cited by 382 · see citing works

Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors

Samochocki, M., Höffle‐Maas, A., Fehrenbacher, A., Jostock, R., Ludwig, J., Christner, C., Radina, M., Zerlin, M., Ullmer, C., Pereira, E. F. R., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045773 · Cited by 345 · see citing works

Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42

LIU, R., Barkhordarian, H., Emadi, S., PARK, C., & Sierks, M. R. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.003 · Cited by 340 · see citing works

Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action

Danysz, W., Parsons, C. G., Möbius, H. J., Stöffler, A., & Quack, G. (2000) · Neurotoxicity Research · doi:10.1007/bf03033787 · Cited by 262 · see citing works

Trophic effect of β-amyloid precursor protein on cerebral cortical neurons in culture

Araki, W., Kitaguchi, N., Tokushima, Y., Ishii, K., Aratake, H., Shimohama, S., Nakamura, S., & Kimura, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81412-3 · Cited by 213 · see citing works

Enhancement of Outward Potassium Current May Participate in β-Amyloid Peptide-Induced Cortical Neuronal Death

Yu, S. P., Farhangrazi, Z. S., Ying, H. S.-C., Yeh, C.-H., & Choi, D. W. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0186 · Cited by 189 · see citing works

Huperzine A attenuates amyloid β‐peptide fragment 25‐35‐induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase‐3 activation

Xiao, X., Zhang, H., & Tang, X. C. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10075 · Cited by 153 · see citing works

Differential Induction of Immediate Early Gene Proteins in Cultured Neurons by β‐Amyloid (Aβ): Association of c‐Jun with Aβ‐Induced Apoptosis

Anderson, A. J., Pike, C. J., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65041487.x · Cited by 134 · see citing works

The expression of amyloid beta protein precursor protects nerve cells from β-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix

Schubert, D. A., & Behl, C. (1993) · Brain Research · doi:10.1016/0006-8993(93)91331-l · Cited by 131 · see citing works

Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein-(1–40) in rat

Wang, R., Zhang, H., & Tang, X. C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01030-5 · Cited by 131 · see citing works

Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine

Wenk, G. L., Parsons, C. G., & Danysz, W. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00007 · Cited by 128 · see citing works

Initiation and maintenance of NGF-stimulated neurite outgrowth requires activation of a phosphoinositide 3-kinase

Jackson, T., Blader, I. J., Hammonds-Odie, L. P., Burga, C. R., Cooke, F. T., Hawkins, P. T., Wolf, A. G., Heldman, K. A., & Theibert, A. B. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.2.289 · Cited by 125 · see citing works

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer’s disease

Maelicke, A., Schrattenholz, A. S., Samochocki, M., Radina, M., & Albuquerque, E. X. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00214-x · Cited by 123 · see citing works

Reserpine impairs spatial working memory performance in monkeys: reversal by the α2-adrenergic agonist clonidine

Cai, J. X., Ma, Y.-Y., Xu, L., & Hu, X.-T. (1993) · Brain Research · doi:10.1016/0006-8993(93)91034-p · Cited by 122 · see citing works

Mitogen‐Activated Protein Kinase‐Dependent and Protein Kinase C‐Dependent Pathways Link the m1 Muscarinic Receptor to β‐Amyloid Precursor Protein Secretion

Haring, R., Fisher, A., Marciano, D., Pittel, Z., Kloog, Y., Zuckerman, A., Eshhar, N., & Heldman, E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052094.x · Cited by 122 · see citing works

Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate

Ved, H. S., Koenig, M. L., Dave, J. R., & Doctor, B. P. (1997) · Neuroreport · doi:10.1097/00001756-199703030-00029 · Cited by 116 · see citing works

Alzheimer?s disease and NGF signaling

Salehi, A., Delcroix, J., & Swaab, D. F. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0091-x · Cited by 112 · see citing works

Huperzine A and tacrine attenuate ?-amyloid peptide-induced oxidative injury

Xiao, X., Wang, R., & Tang, X. C. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000901)61:5 · Cited by 101 · see citing works

The NMDA receptor ion channel: a site for binding of huperzine A

Gordon, R. K., Nigam, S. V., Weitz, J. A., Dave, J. R., Doctor, B. P., & Ved, H. S. (2001) · Journal of Applied Toxicology · doi:10.1002/jat.805 · Cited by 100 · see citing works

Role of neurotransmission in the regulation of amyloid β-protein precursor processing

Nitsch, R. M., & Growdon, J. H. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90325-5 · Cited by 98 · see citing works

Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury

Xiao, X., Yang, J., & Tang, X. C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00695-3 · Cited by 90 · see citing works

Effects of huperzine A on memory deficits and neurotrophic factors production after transient cerebral ischemia and reperfusion in mice

Wang, Z., Tang, L., Yan, H., Wang, Y., & Tang, X. C. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.03.027 · Cited by 90 · see citing works

The Adhesion Function on Acetylcholinesterase Is Located at the Peripheral Anionic Site

Johnson, G., & Moore, S. W. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0705 · Cited by 87 · see citing works

Involvement of amyloid precursor protein in functional synapse formation in cultured hippocampal neurons

Morimoto, T., Ohsawa, I., Takamura, C., Ishiguro, M., & Kohsaka, S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980115)51:2 · Cited by 85 · see citing works

Protective effects of huperzine A on β-amyloid25–35 induced oxidative injury in rat pheochromocytoma cells

Xiao, X., Wang, R., Han, Y., & Tang, X. C. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01088-0 · Cited by 85 · see citing works

Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats

Wang, L., Han, Y., & Tang, X. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00291-0 · Cited by 81 · see citing works

Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production

Tang, L., Wang, R. T., & Tang, X.-C. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.026 · Cited by 79 · see citing works

Regulation of Nicotinic Acetylcholine Receptor Channel Function by Acetylcholinesterase Inhibitors in Rat Hippocampal CA1 Interneurons

Fayuk, D. A., & Yakel, J. L. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000042 · Cited by 72 · see citing works

Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-α in intracerebroventricular β-amyloid-(1–40) infused rats and human embryonic kidney 293 Swedish mutant cells

Zhang, H., Yan, H., & Tang, X. C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.055 · Cited by 70 · see citing works

Huperzine a attenuates mitochondrial dysfunction in β‐amyloid‐treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism

Gao, X., & Tang, X. C. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20791 · Cited by 68 · see citing works

Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons

Yool, D. A., Klugmann, M., McLaughlin, M., Vouyiouklis, D. A., Dimou, L., Barrie, J. A., McCulloch, M. C., Nave, K., & Griffiths, I. R. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010115)63:2 · Cited by 63 · see citing works

Huperzine A attenuates apoptosis and mitochondria‐dependent caspase‐3 in rat cortical neurons

Zhou, J., & Tang, X. C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03107-1 · Cited by 61 · see citing works

Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells

Tang, L., Rui, W. A. N. G., & Tang, X.-C. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00130.x · Cited by 60 · see citing works

Comparison of the effects of natural and synthetic huperzine-A on rat brain cholinergic function in vitro and in vivo

Tang, X.-C., Kindel, G. H., Kozikowski, A. P., & Hanin, I. (1994) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(94)01182-6 · Cited by 60 · see citing works

Huperzine A attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells

Wang, R. C., Xiao, X., & Tang, X. C. (2001) · Neuroreport · doi:10.1097/00001756-200108280-00009 · Cited by 58 · see citing works

Stereoselectivities of enantiomers of huperzine A in protection against β-amyloid25–35-induced injury in PC12 and NG108-15 cells and cholinesterase inhibition in mice

Zhang, H., Liang, Y. Q., Tang, X. C., He, X., & Bai, D. L. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02437-5 · Cited by 56 · see citing works

Transcriptional and Posttranscriptional Mechanisms Involved in the Interleukin‐1, Steroid, and Protein Kinase C Regulation of Nerve Growth Factor in Cortical Astrocytes

Pshenichkin, S. P., Szekely, A. M., & Wise, B. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020419.x · Cited by 56 · see citing works

Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats

Liang, Y., & Tang, X.-C. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00411.x · Cited by 55 · see citing works

Effects of huperzine A on amyloid precursor protein processing and β‐amyloid generation in human embryonic kidney 293 APP Swedish mutant cells

Peng, Y., Jiang, L., Lee, D. Y. W., Schachter, S. C., Ma, Z., & Lemere, C. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20987 · Cited by 53 · see citing works

Transgenic murine cortical neurons expressing human Bcl-2 exhibit increased resistance to amyloid β-peptide neurotoxicity

Saillé, C., Marin, P., Martinou, J., Nicole, A., London, J., & Ceballos-Picot, I. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00089-5 · Cited by 43 · see citing works

The Effect of Cholinesterase Inhibitors on the Secretion of APPS from Rat Brain Cortexa

GIACOBINI, E., MORI, F., & Lai, C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34451.x · Cited by 42 · see citing works

Second generation cholinesterase inhibitors: Effect of (L)‐huperzine‐A on cortical biogenic amines

Zhu, X. ‐., & Giacobini, E. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410613 · Cited by 39 · see citing works

Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys

Ou, L. Y., Tang, X. C., & Cai, J. X. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01500-x · Cited by 38 · see citing works

Improving effects of huperzine A on abnormal lipid peroxidation and superoxide dismutase in aged rats.

Shang, Y., Ye, J. W., & Tang, X. C. (1999) · PubMed · Cited by 36 · see citing works

Efficacy and tolerability of memantine in the treatment of dementia

Rossom, R. C., Adityanjee, & Dysken, M. W. (2004) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2004.12.006 · Cited by 34 · see citing works

Huperzine A protects rat pheochromocytoma cells against oxygen–glucose deprivation

Zhou, J., Fu, Y., & Tang, X. (2001) · Neuroreport · doi:10.1097/00001756-200107200-00007 · Cited by 27 · see citing works

Huperzine A, a nootropic agent, inhibits fast transient potassium current in rat dissociated hippocampal neurons

Li, Y., & Hu, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00167-2 · Cited by 22 · see citing works

Huperzine A attenuates the neurotoxic effect of staurosporine in primary rat cortical neurons

Zhang, H., & Tang, X. C. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00023-5 · Cited by 21 · see citing works

Similar potency of the enantiomers of huperzine A in inhibition of [3H]dizocilpine (MK-801) binding in rat cerebral cortex

Zhang, Y., Chen, X.-Q., Yang, H., Jin, G., Bai, D., & Hu, G. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01615-3 · Cited by 16 · see citing works

Huperzine A inhibits the sustained potassium current in rat dissociated hippocampal neurons

Li, Y., & Hu, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00620-1 · Cited by 15 · see citing works

Apoptosis induced by beta-amyloid25-35 in acetylcholinesterase-overexpressing neuroblastoma cells.

Zhang, H. Y., Brimijoin, S., & Tang, X. (2003) · PubMed · Cited by 14 · see citing works

Neurotrophic Factor Strategies for the Treatment of Alzheimer Disease

Nabeshima, T., & Yamada, K. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00007 · Cited by 13 · see citing works

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., Luchsinger, J. A., Ogunniyi, A., Perry, E. K., Potocnik, F., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70169-8 · Cited by 1,233 · see citing works

Huperzine A from Huperzia species—An ethnopharmacolgical review

Ma, R., Tan, C., Zhu, D., Gang, D. R., & Xiao, P. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.05.030 · Cited by 292 · see citing works

Donepezil: an update

Seltzer, B. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.7.1011 · Cited by 256 · see citing works

A molecular approach in drug development for Alzheimer’s disease

Agatonović-Kuštrin, S., Kettle, C., & Morton, D. W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.147 · Cited by 236 · see citing works

Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer’s Disease

Shal, B., Ding, W., Ali, H., Kim, Y. S., & Khan, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00548 · Cited by 234 · see citing works

Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease

Konrath, E. L., Passos, C. D. S., Klein‐Júnior, L. C., & Henriques, A. T. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12090 · Cited by 219 · see citing works

Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: A comprehensive review

Venkatesan, R., Ji, E., & Kim, S. Y. (2015) · BioMed Research International · doi:10.1155/2015/814068 · Cited by 212 · see citing works

Where is the hope for drug discovery? Let history tell the future

De, K., Li, X., & Zhang, H. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.002 · Cited by 157 · see citing works

Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis

Wang, B.-S., Wang, H., Wei, Z.-H., Song, Y., Zhang, L., & Chen, H. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0189-x · Cited by 148 · see citing works

Natural product for the treatment of Alzheimer’s disease

Bui, T. T., & Nguyễn, T. H. (2017) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2016-0147 · Cited by 146 · see citing works

Natural Products as Promising Drug Candidates for the Treatment of Alzheimer’s Disease: Molecular Mechanism Aspect

Ansari, N., & Khodagholi, F. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040005 · Cited by 131 · see citing works

Traditional Chinese medicines and Alzheimer’s disease

Wu, T., Chen, C.-P., & Jinn, T. (2011) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2011.04.004 · Cited by 115 · see citing works

Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia

Zhang, H., Zheng, C. Y., Yan, H., Wang, Z. F., Tang, L. L., Gao, X., & Tang, X. C. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.049 · Cited by 111 · see citing works

Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy

Arya, A., Chahal, R., Rao, R., Rahman, M. H., Kaushik, D., Akhtar, M. F., Saleem, A., Khalifa, S. M. A., El-Seedi, H. R., Kamel, M., et al. (2021) · Biomolecules · doi:10.3390/biom11030350 · Cited by 111 · see citing works

Huperzine A Activates Wnt/β-Catenin Signaling and Enhances the Nonamyloidogenic Pathway in an Alzheimer Transgenic Mouse Model

Wang, C., Zheng, W. H., Wang, T., Xie, J., Wang, S., Zhao, B., Teng, W., & Wang, Z. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.245 · Cited by 107 · see citing works

Huperzine A protects isolated rat brain mitochondria against β-amyloid peptide

Gao, X., Zheng, C. Y., Yang, L., Tang, X. C., & Zhang, H. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.028 · Cited by 103 · see citing works

Huperzine A exhibits anti‐inflammatory and neuroprotective effects in a rat model of transient focal cerebral ischemia

Wang, Z., Wang, J., Zhang, H., & Tang, X.-C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05504.x · Cited by 95 · see citing works

Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease

Huang, X., Qian, Z., He, X. M., Gong, Q., Wu, K.-C., Jiang, L., Lü, L., Zhu, Z.-J., Zhang, H., Yung, W., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.004 · Cited by 90 · see citing works

Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural features

Ji, H., & Zhang, H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00752.x · Cited by 88 · see citing works

New insights into huperzine A for the treatment of Alzheimer's disease

Zhang, H. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.128 · Cited by 88 · see citing works

Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease

Giulia, N., Sestito, S., Digiacomo, M., & Rapposelli, S. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170607114232 · Cited by 86 · see citing works

Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to polydatin-induced apoptosis in human nasopharyngeal carcinoma CNE cells

Liu, H., Zhao, S., Zhang, Y., Wu, J., Hu, P., Fan, J., & Liao, J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23303 · Cited by 83 · see citing works

Anti-Inflammatory Properties and Regulatory Mechanism of a Novel Derivative of Artemisinin in Experimental Autoimmune Encephalomyelitis

Wang, Z., Qiu, J., Guo, T. B., Liu, A., Wang, Y., Yin, L., & Zhang, J. Z. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5958 · Cited by 81 · see citing works

Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders

Lee, H.-M., & Kim, Y. (2016) · Schizophrenia Research and Treatment · doi:10.1155/2016/6378137 · Cited by 80 · see citing works

Recent Progress in Repositioning Alzheimer'S Disease Drugs Based on a Multitarget Strategy

Santos, M. A., Chand, K., & Chaves, S. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0103 · Cited by 77 · see citing works

Implication of Caspase-3 as a Common Therapeutic Target for Multineurodegenerative Disorders and Its Inhibition Using Nonpeptidyl Natural Compounds

Khan, S. A., Ahmad, K., Al-Shammari, E., Adnan, M., Baig, M. H., Lohani, M., Somvanshi, P., & Haque, S. (2015) · BioMed Research International · doi:10.1155/2015/379817 · Cited by 79 · see citing works

Non-cholinergic Effects of Huperzine A: Beyond Inhibition of Acetylcholinesterase

Zhang, H., Yan, H., & Tang, X. C. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9163-z · Cited by 74 · see citing works

Vascularized neural constructs for ex-vivo reconstitution of blood-brain barrier function

Yue, H., Xie, K., Ji, X., Xu, B., Wang, C., & Shi, P. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119980 · Cited by 73 · see citing works

Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A

Patel, P. A., Patil, S. C., Kalaria, D. R., Kalia, Y. N., & Patravale, V. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.014 · Cited by 73 · see citing works

Can Medical Herbs Stimulate Regeneration or Neuroprotection and Treat Neuropathic Pain in Chemotherapy-Induced Peripheral Neuropathy?

Schröder, S., Beckmann, K. H., Franconi, G., Meyer‐Hamme, G., Friedemann, T., Greten, H. J., Rostock, M., & Efferth, T. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/423713 · Cited by 72 · see citing works

Novel Immunomodulatory Properties of Berbamine through Selective Down-Regulation of STAT4 and Action of IFN-γ in Experimental Autoimmune Encephalomyelitis

Ren, Y., Lü, L., Guo, T. B., Qiu, J., Yang, Y., Liu, A., & Zhang, J. Z. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1491 · Cited by 70 · see citing works

Catalpol attenuates the neurotoxicity induced by β-amyloid1–42 in cortical neuron–glia cultures

Jiang, B., Du, J., Liu, J., Bao, Y., & An, L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.07.105 · Cited by 65 · see citing works

Promising Therapeutics with Natural Bioactive Compounds for Improving Learning and Memory — A Review of Randomized Trials

Kumar, H., More, S. V., Han, S.-D., Choi, J.-Y., & Choi, D. (2012) · Molecules · doi:10.3390/molecules170910503 · Cited by 64 · see citing works

Natural Phenolic Compounds with Neuroprotective Effects

Tavan, M., Hanachi, P., Cádiz‐Gurrea, M. D. L. L., Segura‐Carretero, A., & Mirjalili, M. H. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04046-z · Cited by 62 · see citing works

History and Experience: A Survey of Traditional Chinese Medicine Treatment for Alzheimer′s Disease

Liu, P., Kong, M., Yuan, S., Liu, J., & Wang, P. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/642128 · Cited by 59 · see citing works

Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia

Wang, Y., Huang, L., Tang, X.-C., & Zhang, H. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.46 · Cited by 57 · see citing works

A Systematic Review of Single Chinese Herbs for Alzheimer′s Disease Treatment

Fu, L., & Li, J.-T. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep136 · Cited by 57 · see citing works

From ion channels to complex networks: Magic bullet versus magic shotgun approaches to anticonvulsant pharmacotherapy

Bianchi, M. T., Pathmanathan, J. S., & Cash, S. S. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.09.049 · Cited by 56 · see citing works

Targeting Brain α7 Nicotinic Acetylcholine Receptors in Alzheimer’s Disease: Rationale and Current Status

Vallés, A. S., Borroni, M. V., & Barrantes, F. J. (2014) · CNS Drugs · doi:10.1007/s40263-014-0201-3 · Cited by 55 · see citing works

Decreased Accumulation of Subcellular Amyloid-β with Improved Mitochondrial Function Mediates the Neuroprotective Effect of Huperzine A

Yang, L., Ye, C.-Y., Huang, X., Tang, X.-C., & Zhang, H. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120274 · Cited by 55 · see citing works

A robust and scalable synthesis of the potent neuroprotective agent (−)-huperzine A

Tun, M. K. M., Wüstmann, D.-J., & Herzon, S. B. (2011) · Chemical Science · doi:10.1039/c1sc00455g · Cited by 54 · see citing works

Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders

Singh, A. A., Katiyar, S., & Song, M. (2025) · Brain Sciences · doi:10.3390/brainsci15030252 · Cited by 53 · see citing works

The Neurovascular Protective Effects of Huperzine A on D-Galactose-Induced Inflammatory Damage in the Rat Hippocampus

Ruan, Q., Hu, X., Ao, H., Ma, H., Gao, Z., Liu, F., Kong, D., Bao, Z., & Yu, Z. (2014) · Gerontology · doi:10.1159/000358235 · Cited by 52 · see citing works

Schwann Cell Migration Induced by Earthworm Extract via Activation of PAs and MMP2/9 Mediated through ERK1/2 and p38

Chang, Y., Shih, Y.-T., Chen, Y.-S., Liu, C., Fang, W.-K., Tsai, C., Tsai, F., Kuo, W., Lai, T.-Y., & Huang, C. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep131 · Cited by 52 · see citing works

Huperzine: A response to cognitive impairment and task switching deficits in patients with Alzheimer’s disease

Gul, A., Bakht, J., & Mehmood, F. (2019) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2018.07.004 · Cited by 52 · see citing works

Tacrine-Based Hybrids: Past, Present, and Future

Bubley, A., Erofeev, A. S., Gorelkin, P. V., Beloglazkina, E. K., Majouga, A. G., & Krasnovskaya, O. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021717 · Cited by 50 · see citing works

Huperzine A protects C6 rat glioma cells against oxygen–glucose deprivation‐induced injury

Wang, Z. F., & Tang, X. C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.016 · Cited by 49 · see citing works

Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization

Hauser, P. V., Chang, H.-M., Nishikawa, M., Kimura, H., Yanagawa, N., & Hamon, M. (2021) · Bioengineering · doi:10.3390/bioengineering8110178 · Cited by 50 · see citing works

Traditional Chinese herbal medicine for vascular dementia

Chan, E. S., Bautista, D. T., Zhu, Y., You, Y., Long, J. T., Li, W., & Chen, C. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010284.pub2 · Cited by 48 · see citing works

Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N 2a cells

Tao, Y., Fang, L., Yang, Y., Jiang, H., Yang, H., Zhang, H., & Zhou, H. (2013) · PROTEOMICS · doi:10.1002/pmic.201200437 · Cited by 47 · see citing works

Timosaponin B-II ameliorates scopolamine-induced cognition deficits by attenuating acetylcholinesterase activity and brain oxidative damage in mice

Zhao, X. D., Liu, C., Yu, Q., Fang, L., Luo, J., Bi, K., & Jia, Y. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9877-z · Cited by 47 · see citing works

Huperzine A for vascular dementia

Hao, Z., Liu, M., Liu, Z., & Lu, D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007365.pub2 · Cited by 48 · see citing works

Huperzine A ameliorates cognitive dysfunction and neuroinflammation in kainic acid‐induced epileptic rats by antioxidant activity and NLRP 3/caspase‐1 pathway inhibition

Moghaddam, P. M., Sadr, S. S., Roghani, M., Arabzadeh, S., Khamse, S., Zamani, E., Hosseini, M., & Moradi, F. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13064 · Cited by 46 · see citing works

Gastrodia elata modulates amyloid precursor protein cleavage and cognitive functions in mice

Mishra, M., Huang, J., Lee, Y. Y., Chua, D. S. K., Lin, X., Hu, J., & Heese, K. (2011) · BioScience Trends · doi:10.5582/bst.2011.v5.3.129 · Cited by 44 · see citing works

Progress in the development of new drugs in Alzheimer's disease

Piau, A., Nourhashémi, F., Hein, C., Caillaud, C., & Vellas, B. J. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0012-x · Cited by 41 · see citing works

Plant derived alkaloids in major neurodegenerative diseases: from animal models to clinical trials

Girdhar, S., Girdhar, A., Verma, S. K., Lather, V., & Pandita, D. (2015) · Journal of Ayurvedic and Herbal Medicine · doi:10.31254/jahm.2015.1307 · Cited by 41 · see citing works

Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-γ signaling in a murine model of inflammatory bowel disease

Sun, Y., Wu, X., Ye, Y., Gong, F., Shen, Y., Cai, T., Zhou, X., Wu, X., & Xu, Q. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.014 · Cited by 40 · see citing works

Lipid nanocarriers loaded with natural compounds: Potential new therapies for age related neurodegenerative diseases?

Soares, T., Loureiro, L., Carvalho, A. M., Oliveira, M. E. C. D. R., Dias, A. C. P., Sarmento, B. F. C. C., & Lúcio, M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.04.004 · Cited by 37 · see citing works

Coadministration of huperzine A and ligustrazine phosphate effectively reverses scopolamine-induced amnesia in rats

Shi, J., Liu, Q., Wang, Y., & Luo, G. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.07.004 · Cited by 37 · see citing works

The effects of Huperzine A on dementia and mild cognitive impairment: An overview of systematic reviews

Ghassab‐Abdollahi, N., Mobasseri, K., Ahmadabad, A. D., Nadrian, H., & Mirghafourvand‬‬‬‬‬‬‬‬‬‬‬‬‬‬, M. (2021) · Phytotherapy Research · doi:10.1002/ptr.7126 · Cited by 35 · see citing works

Huperzine A for mild cognitive impairment

Yue, J., Dong, B. R., Lin, X., Yang, M. J., Wu, H. M., & Wu, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008827.pub2 · Cited by 35 · see citing works

Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method

Kitisripanya, N., Saparpakorn, P., Wolschann, P., & Hannongbua, S. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.08.004 · Cited by 34 · see citing works

Xanthoceraside Ameliorates Mitochondrial Dysfunction Contributing to the Improvement of Learning and Memory Impairment in Mice with Intracerebroventricular Injection of Aβ1‐42

Ji, X., Chi, T., Xu, Q., He, X., Xiao-yu, Z., Zhang, R., & Zou, L. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/969342 · Cited by 34 · see citing works

Huperzia serrata Extract ‘NSP01’ With Neuroprotective Effects-Potential Synergies of Huperzine A and Polyphenols

Callizot, N., Campanari, M., Rouvière, L., Jacquemot, G., Henriques, A. T., Garayev, E., & Poindron, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.681532 · Cited by 34 · see citing works

Herbal medicines to treat Alzheimer's disease

Izzo, A. A., & Capasso, F. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.001 · Cited by 34 · see citing works

Protocatechuic Acid from Alpinia oxyphylla Induces Schwann Cell Migration via ERK1/2, JNK and p38 Activation

Ju, D., Kuo, W., Ho, T., Paul, C. R., Kuo, C., Viswanadha, V. P., Lin, C., Chen, Y.-S., Chang, Y., & Huang, C. (2015) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x15500408 · Cited by 33 · see citing works

Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update

Tumiatti, V., Bolognesi, M. L., Minarini, A., Rosini, M., Milelli, A., Matera, R., & Melchiorre, C. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.4.387 · Cited by 33 · see citing works

Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes

Froestl, W., Muhs, A., & Pfeifer, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121537 · Cited by 31 · see citing works

Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget

Mak, S., Li, W., Fu, H., Luo, J., Cui, W., Hu, S., Pang, Y., Carlier, P. R., Tsim, K. W. K., Pi, R., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15379 · Cited by 30 · see citing works

RSC96 Schwann Cell Proliferation and Survival Induced by Dilong through PI3K/Akt Signaling Mediated by IGF‐I

Chang, Y., Kuo, W., Lai, T.-Y., Shih, Y.-T., Tsai, F., Tsai, C., Shu, W.-T., Chen, Y., Chen, Y.-S., Kuo, W., et al. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep216 · Cited by 30 · see citing works

Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A against Oligomeric Aβ42-Induced Injury in Primary Rat Neurons

Lei, Y., Yang, L., Ye, C. Y., Qin, M. Y., Yang, H. Y., Jiang, H. L., Tang, X. C., & Zhang, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128366 · Cited by 30 · see citing works

The Amazonian herbal Marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse Alzheimer model

Figueiró, M., Ilha, J., Linck, V. M., Herrmann, A. P., Nardin, P., Menezes, C. B., Achaval, M., Gonçalves, C. A., Porciúncula, L. O., Nunes, D. S., et al. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.07.013 · Cited by 29 · see citing works

Electrochemical Biosensor for Organophosphate Pesticides and Huperzine‐A Detection Based on Pd Wormlike Nanochains/Graphitic Carbon Nitride Nanocomposites and Acetylcholinesterase

Wang, B., Ye, C., Zhong, X., Chai, Y., Chen, S., & Yuan, R. (2015) · Electroanalysis · doi:10.1002/elan.201500339 · Cited by 28 · see citing works

[+]-Huperzine A Protects Against Soman Toxicity in Guinea Pigs

Wang, Y., Wei, Y., Oguntayo, S., Jensen, N., Doctor, B. P., & Nambiar, M. P. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0564-5 · Cited by 28 · see citing works

Target-oriented multifunctional organocatalysis for enantioselective synthesis of bicyclo[3.3.1]nona-2,6-dien-9-ones. A formal asymmetric synthesis of huperzine A

Ding, X., Li, X., Liu, D., Cui, W., Ju, X., Wang, S., & Yao, Z. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.05.061 · Cited by 28 · see citing works

Phytomolecules as Alzheimer's therapeutics: A comprehensive review

Hussain, M. K., Ahmad, M., Khatoon, S., Khan, M. V., Azmi, S., Arshad, M., Ahamad, S., & Saquib, M. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117401 · Cited by 27 · see citing works

Bis(12)-hupyridone, a novel multifunctional dimer, promotes neuronal differentiation more potently than its monomeric natural analog huperzine A possibly through alpha7 nAChR

Cui, W., Cui, G., Li, W., Zhang, Z., Hu, S., Mak, S., Zhang, H., Carlier, P. R., Choi, C., Wong, Y.-T., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.042 · Cited by 27 · see citing works

Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of α-secretase and BACE-1 concurrently

Fu, H., Dou, J., Li, W., Cui, W., Mak, S., Hu, Q., Luo, J., Lam, C. S. C., Pang, Y., Youdim, M. B. H., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.013 · Cited by 26 · see citing works

Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder

Garza, R. D. L., Verrico, C. D., Newton, T. F., Mahoney, J. J., & Thompson-Lake, D. G. Y. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv098 · Cited by 25 · see citing works

Med PS erver: A database for identification of therapeutic targets and novel leads pertaining to natural products

Potshangbam, A. M., Polavarapu, R., Rathore, R. S., Naresh, D., Prabhu, N. P., Nongdam, P., Kumar, P., & Vindal, V. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13430 · Cited by 25 · see citing works

Original article Assessment of antioxidative activity of alkaloids from Huperzia selago and Diphasiastrum complanatum using in vitro systems

Czapski, G. A., Szypuła, W. J., Kudlik, M., Wileńska, B., Kania, M., Danikiewicz, W., & Adamczyk, A. (2014) · Folia Neuropathologica · doi:10.5114/fn.2014.47840 · Cited by 24 · see citing works

Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment Ameliorate Acetaminophen-Induced Liver Injury in Mice via Central Cholinergic System Regulation

Zhang, J., Zhang, L., Sun, X., Yang, Y., Kong, L., Lu, C., Lv, G., Wang, T., Wang, H., & Fu, F. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.233841 · Cited by 24 · see citing works

Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights

Islam, M. R., Akash, S., Islam, M. M., Sarkar, N., Kumer, A., Chakraborty, S., Dhama, K., Al‐Shaeri, M., Anwar, Y., Wilairatana, P., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148886 · Cited by 27 · see citing works

Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines

Bartolini, M., & Marco, J. L. (2018) · The Chemical Record · doi:10.1002/tcr.201800155 · Cited by 23 · see citing works

Challenges in Designing Therapeutic Agents for Treating Alzheimer’s Disease-from Serendipity to Rationality

Rashid, U., & Ansari, F. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50002-7 · Cited by 23 · see citing works

Lactucopicrin potentiates neuritogenesis and neurotrophic effects by regulating Ca 2+ /CaMKII/ATF1 signaling pathway

Venkatesan, R., Shim, W., Yeo, E., & Kim, S. Y. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.12.035 · Cited by 21 · see citing works

Exposure to CuO Nanoparticles Mediates NFκB Activation and Enhances Amyloid Precursor Protein Expression

Mou, X., Pilozzi, A. R., Tailor, B. A., Yi, J., Cahill, C., Rogers, J., & Huang, X.-D. (2020) · Biomedicines · doi:10.3390/biomedicines8030045 · Cited by 18 · see citing works

Huperzine A protects neural stem cells against Aβ-induced apoptosis in a neural stem cells and microglia co-culture system.

Zhu, N., Lin, J., Wang, K., Meidan, W., Chen, Q., & Wang, Y. (2015) · Europe PMC (PubMed Central) · Cited by 20 · see citing works

Ultrastructural mitochondria changes in perihematomal brain and neuroprotective effects of Huperzine A after acute intracerebral hemorrhage

Lu, H., Lü, L., Jiang, M., Dong, Q., & Zheng, G. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s92158 · Cited by 19 · see citing works

Effects of Catalpol on Alzheimer’s Disease and Its Mechanisms

Chen, H., Deng, C., Meng, Z., & Meng, S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2794243 · Cited by 19 · see citing works

Role of Phytochemicals in Neurotrophins Mediated Regulation of Alzheimer’s Disease

Sharma, B. (2017) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2017.07.00231 · Cited by 19 · see citing works

Phytochemicals as therapeutic interventions in neurodegenerative diseases

Kavitha, R. V., Kumar, J. R., Egbuna, C., & Ifemeje, J. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817890-4.00010-x · Cited by 19 · see citing works

Involvement of M1-muscarinic acetylcholine receptors, protein kinase C and mitogen-activated protein kinase in the effect of huperzine A on secretory amyloid precursor protein-α

Yan, H., Zhang, H. Y., & Tang, X. C. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3280c1e28c · Cited by 19 · see citing works

Huperzine-A, a versatile herb, for the treatment of Alzheimer’s disease

Tsai, S. (2019) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000151 · Cited by 19 · see citing works

Huperzine A and Huperzine B Production by Prothallus Cultures of Huperzia selago (L.) Bernh. ex Schrank et Mart

Szypuła, W. J., Wileńska, B., Misicka, A., & Pietrosiuk, A. (2020) · Molecules · doi:10.3390/molecules25143262 · Cited by 18 · see citing works

Lycopodium Alkaloids: Pharmacology

Ólafsdóttir, E. S., Halldorsdottir, E. S., Pich, N., & Ómarsdóttir, S. (2013) · Springer eBooks · doi:10.1007/978-3-642-22144-6_42 · Cited by 18 · see citing works

Identification of Lycopodium Alkaloids Produced by an Ultraviolet-Irradiated Strain of Paraboeremia, an Endophytic Fungus from Lycopodium serratum var. longipetiolatum

Ishiuchi, K., Hirose, D., Suzuki, T., Nakayama, W., Jiang, W., Monthakantirat, O., Wu, J., Kitanaka, S., & Makino, T. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00627 · Cited by 17 · see citing works

Huperzine A, but not tacrine, stimulates S100B secretion in astrocyte cultures

Lunardi, P. S., Nardin, P., Guerra, M. C., Abib, R. T., Leite, M. C., & Gonçalves, C. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.01.029 · Cited by 16 · see citing works

Bombycis excrementum Reduces Amyloid-β Oligomer-Induced Memory Impairments, Neurodegeneration, and Neuroinflammation in Mice

Moon, M., Choi, J. G., Kim, S. Y., & Oh, M. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140270 · Cited by 16 · see citing works

Terrestrial Plants as a Source of Novel Pharmaceutical Agents

Cragg, G. M. L., Newman, D. J., & Kingston, D. G. I. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00033-2 · Cited by 16 · see citing works

Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia

Zhang, H., Zheng, C. Y., Yan, H., Wang, Z. F., Tang, L. L., Gao, X., & Tang, X. C. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.049 · Cited by 111 · see citing works

Neuroprotective Effects of Huperzine A

Wang, R., & Tang, X. C. (2005) · Neurosignals · doi:10.1159/000085387 · Cited by 175 · see citing works

The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease

Zangara, A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00111-4 · Cited by 208 · see citing works

Non-cholinergic Effects of Huperzine A: Beyond Inhibition of Acetylcholinesterase

Zhang, H., Yan, H., & Tang, X. C. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9163-z · Cited by 74 · see citing works

A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies–Emphasis on Alzheimer’s Disease Pathogenesis

Shukla, M., Wongchitrat, P., & Govitrapong, P. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03530-2 · Cited by 15 · see citing works